The case against Medtronic that will be heard by the U.S. Supreme Court has wide-ranging implications for patients, doctors and device makers. Medtronic asserts that because the FDA has a rigorous approval process for medical devices, federal law "preempts" it from state claims relating to a device's safety and effectiveness. Lower courts have agreed.